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ABSTRACT 
Cancer is one of the dreaded diseases for which no drugs have been invented so far for its complete cure. 
While the world is advancing so fast with the advancement of science and technology, at the same time, 
new dreaded diseases continue to emerge around the world. One such global pandemic disease currently 
witnessing is COVID-19. No exact medicine has been developed to control and cure this new pandemic 
which has a serious impact on aged persons; patients of diabetics, asthma, cancer, pneumonia, etc. Some 
recent and current studies conducted around the world have shown us many facts about this. The present 
study is to conduct a bibliometric analysis of 1457 scholarly communications on the impact of COVID-19 
related to the Cancer indexed in the Web of Science (WoS) Core Collection database which has been 
retrieved. 
Keywords: COVID-19, Cancer, Web of Science, Bibliometrics, Biblioshiny, VOSviewer, SARS-CoV-2, 
Pandemic 
INTRODUCTION 
The cases of patients with pneumonia of unknown cause detected in Wuhan City, China on December 21, 
2019, have been reported by Wuhan Municipal Health Commission, China to the WHO China Country 
Office on December 31, 2019. The outbreak was declared as a Public Health Emergency of International 
Concern on January 30, 2020, by WHO. Thereafter, on February 11, 2020, WHO named it “COVID-19”. 
The rate of spreading of pandemic disease has become very high and fast (Ibohal Singh, 2020). The first 
infection with the severe acute respiratory syndrome (SARS-CoV-2) that leads to coronavirus disease 
(COVID-19) has now grown substantially increasing day by all over the World (Wu & McGoogan, 2020; 
Hanna et al., 2020; Zhou et al., 2020; Liang et al., 2020). COVID-19 has been related to outbreaks of 
asymptomatic infections, severe viral pneumonia, acute syndrome of respiratory difficulty and death 
(Hanna et al., 2020). As of 23rd January 2021, there have been 96,877,399 COVID-19 confirmed cases 
reported in 224 countries (WHO Coronavirus Disease (COVID-19) Dashboard 2021). Older people and 
those dealing with underlying medical problems, such as cardiovascular disease, diabetes, chronic 
respiratory disorders and cancer, continue to experience serious illness (WHO, Coronavirus 2020). There 
is clear evidence that older age has more symptoms of COVID-19 and adverse effects than earlier age; for 
cancer patients, this consideration is highly relevant (Hanna et al., 2020). Having a major impact on cancer 
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patients, the community of these cases currently faces many difficult problems and other crisis. In this 
current COVID-19 pandemic, the safety of patient with cancer has raised. Two fundamental problems of 
patient safety were raised, firstly, patients with cancer must leave their homes to visit the cancer clinic and 
thereby possibly expose themselves to infection. Second, cancer treatments themselves can predispose 
patients to the more serious harmful effects of COVID-19 (Zhou et al., 2020; Liang et al., 2020; Hanna et 
al., 2020). In addition to improved health, cancer patients need online medical advice and proper diagnosis 
and care during this pandemic. Without delay, cancer treatment needs to be done patient by patient and 
delaying could lead a risk to the patient (Wang & Zhang, 2020). 
With a growing interest in COVID-19 research worldwide, many research communications have come upon 
the issue. The present paper is an attempt to assess the trends of research on COVID-19 and its impact on 
cancer treatment taking into account the just past scholarly communications indexed in Web of Science 
Core Collection Database. It addresses the knowledge gap and evaluates the characteristics of the current 
body of literature on COVID-19 and cancer research identifying the contributing authors, institutions and 
countries associated with this burning issue of global concerned. 
SOME JUST PAST AND RECENT STUDIES 
Some leading studies are being reviewed here. ElHawary et al., (2020) made a study on the top 50 cited 
COVID-19 related publications that appeared early during the pandemic. Tao et al. (2020) conducted a 
bibliometric analysis of published documents based on coronavirus from 2000 to 2020 to identify the most 
productive sources, countries, institutions, authors and keywords. In another bibliometrics study, Askun 
and Cizel (2020) studied the mixed methods for twenty years regarding the most cited countries, keyword 
plus cloud, co-occurrence network, co-citation, author collaboration using the R programming language. 
The bibliometrics analysis conducted by Xie et al. (2020) provides a basic worldwide overview of research 
publications on atlantoaxial spine surgery based on the Web of Science and VOSviewer. Dwivedi et al. 
(2017) studied the papers on male breast cancer which were indexed in Science Citation Index-Expanded 
and found that publication in this area has steadily been increased. Chahrour et al. (2020) in their 
bibliometrics study on trends of COVID-19 research since its outbreak using PubMed database and the 
World Health Organization (WHO) database have shown that among the countries, China produced the 
highest number of publications. Zhai et al., 2020 also have studied the research progress of the 
coronaviruses. While He et al. (2020) analyzed the 100 most-cited articles in the field of urological surgery, 
bibliometrics analysis on cancer was carried out by different researchers (Mainwaring et al., 2020; He et 
al., 2020; Shi et al., 2020; Yang et al., 2019; Özen Çınar, 2020; Moral-Munoz et al., 2019). Bibliometrics 
analysis on the other related areas is also conducted recently (Cancino et al., 2019; Ahmi et al., 2019). 
OBJECTIVES OF THE STUDY 
The present study has been taken up with the objectives to 
1. Assess the trends of research on COVID-19 and its impact on cancer patients; 
2. Aware the characteristics of the scholarly communications; 
3. Understand the contributing researchers/authors; 
4. Know the institutions and countries associated with such studies; and 
5. Familiar with most relevant sources and highly cited papers. 
SCOPE AND METHODS 
The present study covers scholarly communications on COVID-19 and its related aspects particularly its 
impact on Cancer patients published worldwide. The data about the study has been searched, identified and 
downloaded from Clarivate Analytics Web of Science (WoS) Core Collection Database. For the purpose, 
an Advanced Search Strategy was launched and conducted on 23rd, 2021, by using search terms provided 
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by MeSH Browser of U.S. National Library of Medicine “TI = (COVID-19* OR 2019-nCoV 
disease* OR 2019 novel coronavirus disease* OR Coronavirus disease-19* OR Coronavirus disease 2019* 
OR COVID-19 virus disease* OR Novel coronavirus disease 2019* OR SARS-CoV-2 disease*) AND TI 
= (Cancer* OR Oncology* OR Carcinoma* OR Malignancy* OR Adenocarcinoma* OR Adenoid cystic 
carcinoma* OR AIDS malignancies* OR Blastomas* OR Leukemia* OR Melanoblastoma* OR 
Melanoma* OR Renal cell carcinoma* OR Rhabdomyosarcoma* OR Sarcoma* OR Squamous cell 
carcinoma* OR Teratocarcinoma* OR Toxohormone* OR Benign-Neoplasms* OR Malignant 
Neoplasms* OR Neoplasia* OR Neoplasm* OR Tumors*)”. Documents published and indexed up to 31st 
of December 2020 has been used for the study. Documents such as Early Access and Correction were 
excluded from the search and analysis. A total of 1457 publications fulfilled the desired search query. The 
data exported in plaintext (.txt) file format from the database is used as the data source. The R Package 
Bibliometrix (Biblioshiny) (Aria & Cuccurullo, 2017) and VOSviewer software (Van Eck & Waltman, 
2009) are used to analyze and visualize the data. 
ANALYSIS, FINDINGS AND DISCUSSION 
Basic Data and Document Types 
The bibliometric profile of the studies concerning COVID-19 and Cancer constitutes the main data source 
for the present study which are found in different types of documents. Table 1 and Table 2 give the details 
of the data sources of the papers under study and their types. Table 1 represents the bibliometric profile of 
global COVID-19 and Cancer researches conducted around the world during the period 2020. The data 
sources imported by using Biblioshiny include 1475 different types of documents which were contributed 
from 375 sources having 15151 references contributed by 9300 authors/researchers. However, the 
appearances of these authors are found to be 11979. As shown, of the 1457 documents considered for the 
study there are 99 single-authored and 9201 multi-authored documents. On the other hand, in author 
collaboration, there are 126 single-authored documents, and 0.157 documents per author, the authors per 
document constitute 6.38. Again, the rate of the co-authors per document is 8.22, while the collaborative 
index of all the 1457 papers being 6.91, as Table 1 highlights. 





Sources (Journals, Books, etc) 375 
Documents 1457 
Average citations per documents 5.209 
Average citations per year per doc 2.609 
References 15151 
Keywords Plus (ID) 917 
Author's Keywords (DE) 1261 
Authors 9300 
Author Appearances 11979 
Authors of single-authored documents 99 
Authors of multi-authored documents 9201 
AUTHORS COLLABORATION   
Single-authored documents 126 
Documents per Author 0.157 
Authors per Document 6.38 
Co-Authors per Documents 8.22 
Collaboration Index 6.91 
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As regards the document types, as the following Table 2 shows, there are seven different types as retrieved 
by the Biblioshiny tool. The highest number of document type available is Article (31.50%) followed by 
Letter (22.10%), Editorial material (21.21%), Meeting Abstract (14.28%) and so on. 
Table 2. Distribution of documents by types 
Document Types Frequency Percentage (%) 
Article 459 31.50 
Letter 322 22.10 
Editorial Material 309 21.21 
Meeting Abstract 208 14.28 
Review 134 9.20 
News Item 23 1.58 
Retraction 2 0.14 
Total 1457 100.00 
 
Highly-Cited Papers 
The following Table 3 and Figure 1 show the characteristics and visualization of the most highly cited and 
productive papers whose Global Citation Score (GCS) ranging from 133-376 which received during the 
study period. As seen, the paper “Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-
19) Pneumonia in Two Patients with Lung Cancer” has received 376 GCS making the most highly-cited 
article followed by the paper “Clinical characteristics of COVID-19-infected cancer patients: a 
retrospective case study in three hospitals within Wuhan, China” with 340 GCS. The third highly-cited 
article “Managing Cancer Care during the COVID-19 Pandemic: Agility and Collaboration toward a 
Common Goal” on the other hand, got 196 GCS. The Total Citation per Year (TCPY) for the first three top 
highly cited articles also follows in a similar pattern as 188, 170 and 98 respectively. However, the Local 
Citation Score (LCS) is lowest in case of the top GCS paper with score 12 only, whereas LCS of the second 
and fifth-ranked papers being 154 and 93 respectively. 
Table 3. Top-10 Highly cited papers 
Title of the Paper 
Author (s); Year 
& Source LCS GCS TCPY 
Pulmonary Pathology of Early-Phase 2019 Novel 
Coronavirus (COVID-19) Pneumonia in Two Patients 
With Lung Cancer (Tian et al., 2020) 
Tian et al.; 2020, 
J Thorac Oncol 12 376 188 
Clinical characteristics of COVID-19-
infected cancer patients: a retrospective case study in 
three hospitals within Wuhan, China (Zhang et al., 
2020) 
Zhang et al.; 
2020, Ann Oncol 154 340 170 
Managing Cancer Care During the COVID-
19 Pandemic: Agility and Collaboration Toward a 
Common Goal (Ueda et al., 2020) 
Ueda et al.; 2020, 
J Natl Compr 
Canc Ne 78 196 98 
Patients with Cancer Appear More Vulnerable to SARS-
CoV-2: A Multicenter Study during the COVID-19 
Outbreak (Dai et al., 2020) 
Dai et al.; 2020, 
Cancer Discov 85 195 97.5 
Clinical impact of COVID-19 on patients with cancer 
(CCC19): a cohort study (Lee et al., 2020) 
Kuderer et al.; 
2020, Lancet 93 187 93.5 
Risk of COVID-19 for patients with cancer (Yang Xia et 
al., 2020) 
Xia Y et al; 2020, 
Lancet Oncol 74 169 84.5 
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Risk of COVID-19 for patients with cancer (Wang & 
Zhang, 2020) 
Wang et al.; 
2020, Lancet 
Oncol 68 163 81.5 
A Practical Approach to the Management 
of Cancer Patients During the Novel Coronavirus 
Disease 2019 (COVID-19) Pandemic: An International 
Collaborative Group (Al‐Shamsi et al., 2020) 
Al-Shamsi HO et 
al.; 2020, 
Oncologist 52 139 69.5 
Case Fatality Rate of Cancer Patients with COVID-19 in 
a New York Hospital System (Mehta et al., 2020) 
 
Mehta et al.; 
2020, Cancer 
Discov 66 136 68 
COVID-19 mortality in patients with cancer on 
chemotherapy or other anticancer treatments: a 
prospective cohort study  (Lee et al., 2020) 
Lee et al.; 2020, 
Lancet 62 133 66.5 
*LCS= Local Citation Score; GCS = Global Citation Score; TCPY= Total Citation Per Year 
The data visualization of the above Table 3 made by VOSviewer also indicates the ranges of the citation 









Sources and Impact Factor 
The total analysed 1457 publications under study were retrieved from 375 journal sources. Of these 375 
journals, the most productive journal having a maximum of 107 publications were from the journal Annals 
of Oncology with 616 citations received, followed by Clinical Cancer Research with 73 publications and 
23 citations and the third most published sources are from the journals Pediatric Blood & Cancer with 46 
publications and 192 citations. Table 4 and Figure 2 give us the most productive 10 journals publishing the 
maximum articles 107, 73, 46 and 39, and so on. However, in terms of the citations received by the articles, 
the journal Lancet Oncology in 5th rank has 935 citations in 36 publications just after the journal in rank 1.  






Annals of Oncology 107 616 14.196 
Clinical Cancer Research 73 23 8.911 
Pediatric Blood & Cancer 46 192 2.486 
European Journal of Cancer 39 152 6.680 
Lancet Oncology 36 935 35.386 
Figure 1. Highly cited paper 
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Radiotherapy and Oncology 33 201 5.252 
Journal of Surgical Oncology 26 25 3.114 
Frontiers in Oncology 25 42 4.137 
International Journal of Radiation Oncology Biology Physics 25 67 6.203 
JAMA Oncology 25 109 22.416 
*JCR-IF = Journal Citation Report-Impact Factor 
Again, contradictory to the number of articles published, the Journal Citation Report-Impact Factor (JCR-
IF) is found to be highest (35.386) in respect of the journal in the 5th rank, i.e., Lancet Oncology followed 
by the journal in the 10th rank i.e., JAMA Oncology with JCR-IF 22.416, Annals of Oncology, the journal 











The following Table 5 gives the source impact of the journals over total citation (TC) and the number of 
publications (NP) and different indices such as h-index, g-index and m-index. 
Table 5. Source Impact 
Source h-index g-index m-index TC NP 
Lancet Oncology 16 30 8 935 36 
Annals of Oncology 9 24 4.5 616 107 
Journal of Thoracic Oncology 5 11 2.5 426 11 
Cancer Discovery 4 12 2 401 12 
Lancet 3 6 1.5 329 6 
Journal of the National Comprehensive Cancer Network 2 4 1 228 4 
Radiotherapy and Oncology 7 13 3.5 201 33 
Pediatric Blood & Cancer 6 13 3 192 46 
Nature Reviews Clinical Oncology 5 7 2.5 185 7 
Oncologist 4 12 2 176 12 
(N ≥ 1) N = h-index value  
*TC= Total Citation; NP= Number of Publications 
The top 10 journals (N ≥1) preferred by the researchers in the field of COVID-19 and Cancer, shares 9.35% 
of total sources outputs. The ‘Lancet Oncology’, is found to be the most preferred journal in which 36 
papers with the highest citation of 935 and with highest h-index (16) and g-index (30) were published. The 
journal ‘Annals of Oncology’, is also found to be second most highly cited journals with 616 citations 




received having h-index (9), g-index (24) and m-index (4.5). The ‘Journal of The National Comprehensive 
Cancer Network’, and ‘Lancet’ contributed 2 and 3 h-index which is lowest when the TC stands at 228 and 
329 respectively. 
Research Productivity 
The most productive and influential authors, countries and affiliations publishing the papers are presented 
in Table 6. As seen, 20 authors of different countries of the world contributed papers on COVID-19 and 
Cancer-related aspects in 2020, the number of contributions ranging from 7-14 papers. The productivity is 
highest in respect of the USA with 1566 number of papers, of which the Huazhong Univ Sci and Technol 
shares 89 and Curigliano G with 14 papers are found to be the most productive and influential author among 
others followed by Peters S with 13 papers and Grossi F with 10 papers, Di Maio M, Lambertini M, Rogado 
J, Sullivan R and Tagliamento M with 9 papers each contribution.  
Table 6. Productivity by authors, countries and affiliations 
Authors NP Countries Freq Affiliation NP 
Curigliano G 14 USA 1566 Huazhong Univ Sci and Technol 89 
Peters S 13 Italy 1309 Univ Texas Md Anderson Canc Ctr 77 
Grossi F 10 UK 734 Mem Sloan Kettering Canc Ctr 64 
Di Maio M 9 France 638 Wuhan Univ 64 
Lambertini M 9 China 496 Univ Toronto 56 
Rogado J 9 Spain 348 Harvard Med Sch 55 
Sullivan R 9 Canada 269 Univ Milan 51 
Tagliamento M 9 Germany 209 Inst Canc Res 40 
Ferrari A 8 Australia 193 Fdn Irccs Ist Nazl Tumori 36 
Indini A 8 Netherlands 178 Univ Washington 36 
Xie Ch 8 Brazil 154 Icahn Sch Med Mt Sinai 35 
Barlesi F 7 India 150 Univ Calif San Francisco 35 
Chopra N 7 Turkey 109 IRCCS Osped Policlin San Martino 34 
Choueiri Tk 7 Switzerland 96 Univ Michigan 34 
Ghidini M 7 Belgium 86 Radiat Oncol Ctr 33 
Lou E 7 Singapore 62 Royal Marsden Nhs Fdn Trust 30 
Magrini Sm 7 Austria 58 Univ Birmingham 30 
Scotte F 7 Saudi Arabia 54 Univ Genoa 30 
Wang J 7 Greece 49 Inst Curie 29 
Wang L 7 Japan 42 Dana Farber Canc Inst 27 
*NP = Number of Publications 
Most Cited Countries 
USA is found to be the most cited country of the top 10 countries in research productivity in COVID-19 
and cancer-related aspects, the total citations and the average citations being 2216 and 6.576 respectively 
as the Table 7 shows. 
Table 7. Most cited top 10 Countries 
Country Total Citations Average Article Citations 
USA 2216 6.576 
China 1703 13.409 
United Kingdom 984 7.569 
Italy 882 4.18 





The USA has been followed by China with 1703 citations followed by the United Kingdom with 984 
citations. The other cited countries include Italy, France, Canada and the United Arab Emirates, with 882, 
274, 182 and 174 respectively. Among the top 10 most cited countries, the highest average citation per 
publication (43.5) is received by the United Arab Emirates followed by China (13.409), Switzerland 
(9.143), and United Kingdom (7.569) and so on. 
Concerning the corresponding author’s countries contributions, as Table 8 shows, the USA has the highest 
corresponding authors with 337 articles, 275 SCP and 62 MCP. Italy occupied second with 211 articles, 
177 SCP and 34 MCP followed by the United Kingdom with 130 articles, 96 SCP and 34 MCP. 
Table 8. Top ten corresponding author’s countries 







USA 337 0.268526 275 62 0.184 
Italy 211 0.168127 177 34 0.1611 
United Kingdom 130 0.103586 96 34 0.2615 
China 127 0.101195 96 31 0.2441 
France 63 0.050199 54 9 0.1429 
India 48 0.038247 41 7 0.1458 
Spain 35 0.027888 30 5 0.1429 
Canada 32 0.025498 23 9 0.2812 
Turkey 27 0.021514 25 2 0.0741 
Brazil 26 0.020717 22 4 0.1538 
Keywords Analysis  
Authors Keywords and Keyword plus 
From WoS records, there are a set of 1185 author keywords of which 270 meet the threshold. From Table 
9 and Figure 3, it is seen that “covid-19”, “cancer” and “sars-cov-2” are the top three author keywords 
with a frequency of occurrences 444, 132 and 118, respectively. Keywords such as “coronavirus”, 
“pandemic”, “breast cancer” with a frequency of occurrences 85, 73 and 447 respectively also have a good 
performance. Further, 898 sets of keyword plus were appeared out of which 279 meet the threshold. Also, 
the keyword plus such as “impact” with an occurrence of 40, “china” with 37 and “pneumonia” with 34 
are found as shown in Figure 4.  The keywords such as “chemotherapy” and “survival” with 30 
occurrences each are also found. Due to the outbreak pandemic of COVID-19 all over the world, it is 
evident that research on COVID-19 has been enormously increased thereby the research publication on 
“COVID-19 and Cancer” is gradually increasing. 
Table 9. Top 15 most representative author keywords and keyword plus 
Authors  
Keywords 
Occurrences  Links TLS  Keyword  
Plus 
Occurrences Links TLS 
covid-19 444 243 1167 impact 40 78 137 
cancer 132 125 451 china 37 57 153 
sars-cov-2 118 110 379 pneumonia 34 55 120 
coronavirus 85 105 293 therapy 33 102 148 
Canada 182 5.688 
United Arab Emirates 174 43.5 
Switzerland 128 9.143 
Netherlands 113 6.278 
Australia 97 4.409 
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pandemic 73 84 248 coronavirus 31 63 125 
breast cancer 44 51 118 chemotherapy 30 92 130 
oncology 39 51 138 survival 30 69 120 
lung cancer 28 47 79 cancer 29 36 45 
chemotherapy 27 50 108 risk 29 82 112 
immunotherapy 27 36 97 mortality 28 59 105 
radiotherapy 25 31 80 multicenter 25 62 123 
cancer patients 22 39 64 care 24 56 69 
telemedicine 22 35 73 outcomes 23 55 89 
head and neck cancer 20 25 50 radiotherapy 23 57 97 
surgery 20 34 70 wuhan 23 36 94 









Co-citation Analysis (Cited Sources) 
In the study, a total of 4743 sources are identified and set a minimum number of citations of a source at 20 
in which 176 sources meet the threshold. As the Table 10 and Figure 5 show, Lancet Oncol is the most 
prolific source with a citation of 1260 having total link strength of 26684, followed by the journal New Engl 
J Med with 997 citations having 27111 total link strength. Whereas the Eur J Cancer with 226 citations 
having 6669 total link strength is the lowest. 
Table 10. Top 10 co-cited sources with their total link strength 
Sources Citation Total Link Strength 
Lancet Oncol 1260 26684 
New Engl J Med 997 27111 
Lancet 987 25121 
ama-J Am Med Assoc 604 14411 
J Clin Oncol 597 20034 
Ann Oncol 545 14866 
Jama Oncol 316 8036 
Int J Radiat Oncol 269 7609 
Cancer Discov 238 6199 
Eur J Cancer 226 6669 
 
















Most Cited References 
The ten most local cited references are shown in Table 11 and its corresponding Figure 6. For this purpose, 
the first author, the publication year, the source journal, volume, page number and doi of cited references 
were extracted by the R Package Biblioshiny and data visualization are done by VOSviewer software as 
shown in the figure. “liang wh, 2020, lancet oncol, v21, p335, doi 10.1016/s1470-2045(20)30096-6” has 
topped the list having cited 455 times by the papers published in the area of COVID-19 and Cancer. It has 
become the highest most cited reference during 2020. The lowest citations in this regards are 78 in the 
lowest rank of the list under the table. 
Table 11. Most Cited References 
Cited References Citations 
Liang Wh, 2020, Lancet Oncol, V21, P335, Doi 10.1016/S1470-2045(20)30096-6 455 
Zhang L, 2020, Ann Oncol, V31, P894, Doi 10.1016/J.Annonc.2020.03.296 154 
Yu J, 2020, JAMA Oncol, V6, P1108, Doi 10.1001/Jamaoncol.2020.0980 119 
Guan W, 2020, New Engl J Med, V382, P1708, Doi 10.1056/Nejmoa2002032 118 
Huang Cl, 2020, Lancet, V395, P497, Doi 10.1016/S0140-6736(20)30183-5 107 
Zhou F, 2020, Lancet, V395, P1054, Doi 10.1016/S0140-6736(20)30566-3 101 
Kuderer Nm, 2020, Lancet, V395, P1907, Doi 10.1016/S0140-6736(20)31187-9 93 
Wang Dw, 2020, JAMA-J Am Med Assoc, V323, P1061, Doi 10.1001/Jama.2020.1585 89 
Dai My, 2020, Cancer Discov, V10, P783, Doi 10.1158/2159-8290.Cd-20-0422 85 
































Bibliometrics is one of the thrust areas of research in the field of Library and Information Science. The 
recent outbreak of COVID-19 and its impact on various fronts has been studied in different perspectives 
across the world, as understood from the bibliometric studies. Impact of COVID-19 on cancer patients on 
various issues is found to be given importance by the researchers on which studies have increasingly been 
carried out since recent past. The findings of the present bibliometric study throw us light on many clues 
on the same. A sizeable number of articles on the said aspects are found to be indexed in the Web of Science 
Core Collection database. Application of R Package Biblioshiny and data visualization software 
VOSviewer in analysing the data and their visualization could provide different perspectives of the recent 
and current scholarly communications on COVID-19 and its common impact on Cancer patients and their 
treatments as well. The authors hope to disseminate knowledge that could help researchers to recognize the 
important topic, study characteristics, and gaps in the literature by highlighting the features of COVID-19 
and cancer related articles. As the findings and discussions made the show, the metrics of the papers on the 
issue indicate the significance of the studies in combating the pandemic as well as its impact on cancer 
patients.The trends of research on the issue and other aspects in the days to come are also expected to 
increase significantly. 
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